Please login to the form below

Not currently logged in
Email:
Password:

Breo

This page shows the latest Breo news and features for those working in and with pharma, biotech and healthcare.

Advair generics and acquisitions to hit GSK in 2019

Advair generics and acquisitions to hit GSK in 2019

However the tough US market took a bite out of Breo Ellipta, which saw sales decline (3% AER, 1% CER) because of pricing pressure, despite strong volume growth.

Latest news

More from news
Approximately 11 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Pharma deals during May 2013 Pharma deals during May 2013

    First in this was the purchase for $1bn of 21 per cent of the respiratory product royalties Theravance receives, including the royalties on the recently US approved Breo for COPD being

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics